Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31191106 | 0.82 | CTSA (0.36) | — | |
| SCHEMBL4618579 | 0.81 | TSHR (0.31) | — | |
| SCHEMBL11525439 | 0.80 | TSHR (0.34) | — | |
| SCHEMBL11525772 | 0.79 | TSHR (0.33) | — | |
| SCHEMBL11524942 | 0.78 | — | — | |
| SCHEMBL776263 | 0.77 | LAP3 (0.36) | LAP3 | |
| SCHEMBL6487 | 0.76 | LAP3 (0.32) | LAP3 | |
| SCHEMBL1251447 | 0.75 | PPARD (0.35) | LAP3 | |
| SCHEMBL11745106 | 0.75 | LAP3 (0.34) | LAP3 | |
| SCHEMBL3090613 | 0.74 | METAP1 (0.36) | LAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115836065-A | Methods of making JAK1 inhibitors | 因赛特公司 | 2023-03-21 | — | — | CN | claimed |
| CN-114512716-A | Gel electrolyte and preparation and application of precursor electrolyte thereof | 中南大学 | 2022-05-17 | — | — | CN | claimed |
| US-8062816-B2 | Phosphonate hole blocking layer photoconductors | XEROX CORPORATION (US) | 2011-11-22 | — | — | US | claimed |
| US-8053151-B2 | Phosphonate containing photoconductors | XEROX CORPORATION (US) | 2011-11-08 | — | — | US | claimed |
| EP-2141545-A1 | Phosphonate containing photoconductors | Xerox Corporation (US) | 2010-01-06 | — | — | EP | claimed |
| US-20090325091-A1 | PHOSPHONATE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-31 | — | — | US | claimed |
| US-20090297967-A1 | PHOSPHONATE HOLE BLOCKING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-03 | — | — | US | claimed |
| EP-2128709-A1 | Phosphonate Hole Blocking Layer Photoconductors | Xerox Corporation (US) | 2009-12-02 | — | — | EP | claimed |
| EP-3694846-B1 | 1-BENZYL-2-IMINO-4-PHENYL-5-OXOIMIDAZOLIDINE DERIVATIVES AS HIV PROTEASE INHIBITORS | GILEAD SCIENCES INC (US) | 2024-05-08 | — | — | EP | disclosed |
| CN-115010754-A | Preparation method of (1-cyanoethyl) diethyl phosphate | 苏州昊帆生物股份有限公司 | 2022-09-06 | — | — | CN | disclosed |
| EP-3808743-B1 | HIV REPLICATION INHIBITING PYRIMIDINES | JANSSEN PHARMACEUTICA NV (BE) | 2022-07-20 | — | — | EP | disclosed |
| US-11352329-B2 | HIV protease inhibitors | GILEAD SCIENCES, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| CN-114512716-A | Gel electrolyte and preparation and application of precursor electrolyte thereof | 中南大学 | 2022-05-17 | — | — | CN | disclosed |
| CN-111018771-B | Method for synthesizing 3- (2-cyanovinyl) indole derivative | 中国科学院大连化学物理研究所 | 2022-03-29 | — | — | CN | disclosed |
| WO-2004050068-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A PHYSIOLOGICALLY TOLERABLE WATER-SOLUBLE ACID RESPECTIVELY BASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-06-17 | — | — | WO | disclosed |
| EP-1419152-A1 | HIV INHIBITING PYRIMIDINES DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-05-19 | — | — | EP | disclosed |
| WO-2003016306-A1 | HIV INHIBITING PYRIMIDINES DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-02-27 | — | — | WO | disclosed |
| US-6284779-B1 | NERVOUS SYSTEM DISORDERS | SCHERING AKTIIENGESELLSCHAFT (DE) | 2001-09-04 | — | — | US | disclosed |
| WO-2000046222-A1 | HETEROAROMATIC COMPOUNDS WITH NEURONAL ACTIVITY | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-08-10 | — | — | WO | disclosed |
| US-4151229-A | Process for the manufacture of aminoalkyl-phosponic acid esters | CIBA-GEIGY CORPORATION (US) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352329-B2 | HIV protease inhibitors | PRSS1, SERPINB1, FURIN | LAP3 265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.